ambroxol
UkraineDrugs containing this active substance
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its excretion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs characterized by impaired mucus secretion and poor clearance from the body.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC: R05CB06
Manufacturer: KUSUM FARM LLC
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs characterized by impaired mucus secretion or poor mucus clearance.
Form: syrup
Active substance Dosage ambroxol 30 mg/5 ml ATC: R05CB06
Manufacturer: KUSUM FARM LLC
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs characterized by impaired mucus secretion or poor clearance from the airways.
Form: solution for inhalation and oral use
Active substance Dosage ambroxol 15 mg/2 ml ATC: R05CB06
Manufacturer: KUSUM FARM LLC
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs characterized by impaired mucus secretion or poor mucus clearance.
Form: tablets, extended-release
Active substance Dosage ambroxol 75 mg ATC: R05CB06
Manufacturer: KUSUM FARM LLC
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs, characterized by impaired mucus secretion and poor clearance from the body.
Form: capsules, extended-release
Active substance Dosage ambroxol 75 mg ATC: R05CB06
Manufacturer: KUSUM FARM LLC
-
The drug is indicated to enhance pulmonary surfactant production in preterm infants and newborns with respiratory distress syndrome.
Form: solution for injection
Active substance Dosage ambroxol 7.5 mg/ml ATC: R05CB06
Manufacturer: Farmasel LLC
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulty in its excretion.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC: R05CB06
Manufacturer: JSC "Sofarma" (manufacturing of unpackaged products, primary and secondary packaging; batch release authorization)
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired secretion and difficult mucus clearance.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: LLC "Research Plant "GNCLS" (all manufacturing stages, quality control, batch release)
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired secretion and difficulty in mucus expectoration.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC: R05CB06
Manufacturer: Ternofarm LLC
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulty in its excretion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: Ternofarm LLC
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulties in its excretion.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC: R05CB06
Manufacturer: PJSC "HIMFARMZAVOD "CHERVONA ZIRKA"
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulty in its excretion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: PJSC "Kyivmedpreparat"
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulty in its excretion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: Kusum HealthCare Pvt Ltd
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired secretion and excretion of mucus.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC: R05CB06
Manufacturer: DKP "Pharmaceutical Factory" LLC
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in expectorating phlegm.
Form: syrup
Active substance Dosage ambroxol 30 mg/5 ml ATC: R05CB06
Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulties in its excretion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: ASTRAFARM LLC
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired sputum secretion and difficulty in its expulsion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyi Chemical-Pharmaceutical Plant" (full-cycle manufacturing)
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its excretion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: PJSC "HIMFARMZAVOD "CHERVONA ZIRKA"
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired secretion and excretion of mucus.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulties in its excretion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is indicated to enhance pulmonary surfactant production in preterm infants and newborns with respiratory distress syndrome.
Form: solution for infusion
Active substance Dosage ambroxol 7.5 mg/ml ATC: R05CB06
Manufacturer: JSC "Lubnipharm"
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its expulsion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulties in its excretion.
Form: capsules, extended-release, hard
Active substance Dosage ambroxol 75 mg ATC: R05CB06
Manufacturer: Merckle GmbH (primary and secondary packaging, batch control; permission for batch release)
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired secretion and difficult mucus expectoration.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC: R05CB06
Manufacturer: Merckle GmbH (batch release authorization; unpackaged product manufacturing, primary and secondary packaging, quality control)
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its expectoration.
Form: solution, oral
Active substance Dosage ambroxol 7.5 mg/ml ATC: R05CB06
Manufacturer: Merkle GmbH (production of unpackaged product, primary and secondary packaging, batch control; batch release authorization)
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its removal.
Form: solution for inhalation and oral use
Active substance Dosage ambroxol 15 mg/2 ml ATC: R05CB06
Manufacturer: LLC "Corporation "Zdorovya"
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its excretion.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC: R05CB06
Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulties in its excretion.
Form: syrup
Active substance Dosage ambroxol 30 mg/5 ml ATC: R05CB06
Manufacturer: Corporation "Zdorovya" LLC (all manufacturing stages, quality control, batch release)
-
The drug is used to treat acute and chronic respiratory diseases accompanied by difficulty in expectorating viscous sputum.
Form: tablets
Active substance Dosage ambroxol 15 mg ketotifen 1 mg dry extract of licorice root 10 mg theobromine 50 mg ATC: R05FB01
Manufacturer: PJSC "HIMFARMZAVOD "CHERVONA ZIRKA"
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulty in its excretion.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC: R05CB06
Manufacturer: VETPROM AD, production unit Vifarma
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its excretion.
Form: syrup
Active substance Dosage ambroxol 30 mg/5 ml ATC: R05CB06
Manufacturer: VETPROM AD, production unit Vifarma
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulties in its excretion.
Form: solution, oral
Active substance Dosage ambroxol 3 mg/ml ATC: R05CB06
Manufacturer: Berlin-Chemie AG
-
The drug is used to treat acute and chronic respiratory diseases accompanied by impaired secretion and difficult mucus expectoration.
Form: solution, oral
Active substance Dosage ambroxol 30 mg/5 ml ATC: R05CB06
Manufacturer: Berlin-Chemie AG (bulk manufacturing, packaging, quality control and batch release)
-
The drug is used for the treatment of acute and chronic bronchial diseases accompanied by impaired secretion and difficulty in mucus expulsion.
Form: tablets, effervescent
Active substance Dosage ambroxol 60 mg ATC: R05CB06
Manufacturer: Hermes Pharma GmbH (manufacturer performing bulk manufacturing, packaging, quality control)
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulties in its excretion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: Berlin-Chemie AG (bulk manufacturing, packaging, quality control and batch release)
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its excretion.
Form: tablets
Active substance Dosage ambroxol 30 mg ATC: R05CB06
Manufacturer: Delpharm Reims
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its excretion.
Form: solution for inhalation and oral use
Active substance Dosage ambroxol 15 mg/2 ml ATC: R05CB06
Manufacturer: Istituto de Angelis S.r.l.
-
The drug is used to enhance pulmonary surfactant production in preterm infants and newborns with respiratory distress syndrome.
Form: solution for infusion
Active substance Dosage ambroxol 15 mg/2 ml ATC: R05CB06
Manufacturer: Sanofi S.R.L.
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulties in its excretion.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml ATC: R05CB06
Manufacturer: Boehringer Ingelheim Espana, S.A.
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its excretion.
Form: syrup
Active substance Dosage ambroxol 30 mg/5 ml ATC: R05CB06
Manufacturer: Delpharm Reims
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired secretion and difficulty in mucus removal.
Form: solution for inhalation and oral use
Active substance Dosage ambroxol 7.5 mg/ml ATC: R05CB06
Manufacturer: Farmasel LLC
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired mucus secretion and difficulty in its excretion.
Form: capsules, extended-release
Active substance Dosage ambroxol 75 mg ATC: R05CB06
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co. KG (manufacturing, quality control)
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired secretion and difficulties in mucus expulsion.
Form: powder for oral solution
Active substance Dosage ambroxol 30 mg ascorbic acid 200 mg ATC: R05CB10
Manufacturer: IksEl Laboratories Pvt. Ltd.
-
The drug is used for acute and chronic respiratory diseases accompanied by difficult phlegm expectoration (e.g., bronchitis, pneumonia, bronchial asthma, bronchiectatic disease). It is also used for inflammation of the middle ear and paranasal sinuses.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml carbocysteine 100 mg/5 ml ATC: R05CB10
Manufacturer: Gracure Pharmaceuticals LTD
-
The drug is used to enhance pulmonary surfactant production in preterm infants and newborns with respiratory distress syndrome.
Form: solution for injection
Active substance Dosage ambroxol 7.5 mg/ml ATC: R05CB06
Manufacturer: LLC "Research Plant "GNCLS" (quality control, batch release)
-
The drug is used for acute and chronic respiratory diseases accompanied by difficult phlegm expectoration (e.g., pneumonia, bronchial asthma, chronic obstructive pulmonary disease). It is also used for inflammation of the middle ear and paranasal sinuses.
Form: syrup
Active substance Dosage ambroxol 15 mg/5 ml carbocysteine 100 mg/5 ml ATC: R05CB10
Manufacturer: Farmak JSC
-
The drug is used to treat acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulty in its excretion.
Form: syrup
Active substance Dosage ambroxol 6 mg/ml ATC: R05CB06
Manufacturer: Farmak JSC
-
The drug is used for the treatment of acute and chronic diseases of the bronchi and lungs accompanied by impaired mucus secretion and difficulties in its excretion.
Form: syrup
Active substance Dosage ambroxol 3 mg/ml ATC: R05CB06
Manufacturer: Farmak JSC
-
The drug is used for the treatment of acute and chronic respiratory diseases accompanied by impaired secretion and excretion of phlegm. This includes bronchitis, pneumonia, bronchial asthma, laryngitis, tracheitis, and other diseases.
Form: tablets, film-coated
Active substance Dosage acetylcysteine 200 mg ambroxol 30 mg ATC: R05CB10
Manufacturer: Sava HealthCare Ltd